VR surgical guidance platform Augmedics announced the launch of a new set of FDA-cleared features, following its 3,000th patent milestone.
The update includes AI image enhancement and customizable views, expanding the capabilities of the company’s xvision, Spine System. The system's clearance has been extended to cover cervical and iliosacral indications, allowing surgeons to benefit from xvision's navigation system in posterior cervical and pelvic approaches, where anatomic visualization challenges exist. The rollout of the solution, which began in January, will be completed by the end of the first quarter and is the company’s largest, since the commercial launch of xvision .
Analyst QuickTake: The announcement of additional xvision features follows growth in Augmedics consumer base, with the company having received a federal supply schedule contract in November 2022 , and having completed 2,000 commercial xvision cases in August 2022 .
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.